跳至主要内容
临床试验/NCT06082583
NCT06082583尚未招募2 期

A Randomized Controlled Trial of the Efficacy of Combining Traditional Tibetan and Remote Ischemic Conditioning on High Altitude Polycythemia

Capital Medical University0 个研究点目标入组 300 人开始时间: 2023年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
300
主要终点
The incidence of effective treatment

研究概览

简要总结

A multicenter, randomized controlled trial was designed to evaluate the effectiveness and safety of the comprehensive traditional Tibetan medicine program combined with remote ischemic conditioning on high altitude polycythemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with high-altitude polycythemia aging 18 to 65 years.

排除标准

  • Allergic to Tibetan medicine ingredients;
  • Inappropriate to receive Tibetan medicine treatment and/or remote ischemic conditioning.

研究组 & 干预措施

Tibetan Medicine Group

Active Comparator

干预措施: Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill) (Drug)

Tibetan Medicine-Remote Ischemic Conditioning Group

Experimental

干预措施: Remote Ischemic Conditioning (Device)

Tibetan Medicine-Remote Ischemic Conditioning Group

Experimental

干预措施: Tibetan Medicine (Shiliu Jianwei Powder, Ershiwuwei Yuganzi Pills, Qiwei Tiexue Pill) (Drug)

结局指标

主要结局

The incidence of effective treatment

时间窗: Baseline and 1 month after treatment.

The hemoglobin levels decreased ≥20% after treatment compared to pre-treatment.

次要结局

未报告次要终点

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Xunming,MD,PhD

Principal Investigator

Capital Medical University

相似试验